ZIM Laboratories informs about press release

21 Jul 2025 Evaluate
ZIM Laboratories has informed that it enclosed the Press Release relating to grant of Marketing Authorization for ‘Rizatriptan Benzoate Orally Disintegrating Strips’ in Australia by the Therapeutic Goods Administration (TGA), to ZIMTAS PTY LTD. (‘ZIMTAS’), Subsidiary of the company.

The above information is a part of company’s filings submitted to BSE. 

Zim Laboratories Share Price

70.84 -5.26 (-6.91%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×